It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
The trial is the largest to date evaluating Leqvio and the first to focus on patient-centered outcomes
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
The trial targets MCAS/MCAD, an under-recognized, debilitating condition with an unknown cause and no cure
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
Breakthrough Therapy designation for pain associated with DPN granted by FDA
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
Strategies aimed at solving the current overdose epidemic must go beyond the identification of risk
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
